ZHW-29034-69560 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-19
Dose 1 — Pfizer-BioNTech
2021-01-09
Dose 2 — Pfizer-BioNTech
2021-01-10
Registered in v-safe
2021-01-10
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-10
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-11
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Redness · Chills · Be unable to work

Adult check-in
2021-01-11
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

1 call case(s)
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Redness, Swelling · None

Adult check-in
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-25
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-02
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-09
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-15
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-22
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-11
Survey response — 6 months, dose 2
MedDRA: Fatigue, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Much hoped for pregnancy. Conceived end of February. Mild pregnancy-associated fatigue but otherwise well.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-11
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-14
Call 1 — Left Voicemail
2021-10-01
Dose 3 — Pfizer-BioNTech
2021-10-03
Survey response — days 1–6 daily, dose 3
MedDRA: Pregnancy — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: I am also 33 weeks pregnant

MedDRA releases: 2024-11 · check-in free text available
2021-10-04
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-06
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-07
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-08
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-10-16
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-10-31
Survey response — day 28, dose 3
MedDRA: Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: New diagnosis of pre-eclampsia

MedDRA releases: 2024-11 · check-in free text available
2021-10-31
Report sent to call center — day 28, dose 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2021-11-04
Call 1 — Left Voicemail
2022-01-02
Survey response — 3 months, dose 3
MedDRA: Labour induction, Pre-eclampsia — Feeling: Good · Be unable to work or attend school

Free text: Pre-eclampsia, needed to be induced at 37 weeks gestation

MedDRA releases: 2024-11 · check-in free text available
2022-02-03
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-04-03
Survey response — 6 months, dose 3
MedDRA: Perinatal depression — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Postpartum depression

MedDRA releases: 2024-11 · check-in free text available
2022-04-03
Report sent to call center — 6 months, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-04-19
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-19	Pfizer-BioNTech
2	2021-01-09	Pfizer-BioNTech
3	2021-10-01	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-01-10	priority 2/3
2021-01-11	priority 2/3
2021-07-11	Successful	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2021-10-31	Successful 2022-02-03	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-04-03	Unsuccessful

Free text

Release 9 — 6 months, dose 2

2021-07-11

Symptoms: Much hoped for pregnancy. Conceived end of February. Mild pregnancy-associated fatigue but otherwise well.

Release 9 — days 1–6 daily, dose 3

2021-10-03

Systemic reaction (other): I am also 33 weeks pregnant

Release 10 — day 28, dose 3

2021-10-31

Symptoms: New diagnosis of pre-eclampsia

Release 10 — 3 months, dose 3

2022-01-02

Symptoms: Pre-eclampsia, needed to be induced at 37 weeks gestation

Release 11 — 6 months, dose 3

2022-04-03

Symptoms: Postpartum depression

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Fatigue	✓	✓	○
SD	Labour induction	·	·	✓
SD	Pain	○	○	○
SD	Perinatal depression	·	·	✓
SD	Pre-eclampsia	·	·	✓
SD	Pregnancy	✓	✓	✓
SRO	Pregnancy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release